707 related articles for article (PubMed ID: 27797940)
21. Faecal immunochemical test accuracy in patients referred for surveillance colonoscopy: a multi-centre cohort study.
Terhaar sive Droste JS; van Turenhout ST; Oort FA; van der Hulst RW; Steeman VA; Coblijn U; van der Eem L; Duijkers R; Bouman AA; Meijer GA; Depla AC; Scholten P; Loffeld RJ; Coupé VM; Mulder CJ
BMC Gastroenterol; 2012 Jul; 12():94. PubMed ID: 22828158
[TBL] [Abstract][Full Text] [Related]
22. Fecal Bacteria Act as Novel Biomarkers for Noninvasive Diagnosis of Colorectal Cancer.
Liang Q; Chiu J; Chen Y; Huang Y; Higashimori A; Fang J; Brim H; Ashktorab H; Ng SC; Ng SSM; Zheng S; Chan FKL; Sung JJY; Yu J
Clin Cancer Res; 2017 Apr; 23(8):2061-2070. PubMed ID: 27697996
[No Abstract] [Full Text] [Related]
23. Leveraging Fecal Microbial Markers to Improve the Diagnostic Accuracy of the Fecal Immunochemical Test for Advanced Colorectal Adenoma.
Zhang Y; Lu M; Lu B; Liu C; Ma Y; Liu L; Miao X; Qin J; Chen H; Dai M
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00389. PubMed ID: 34408121
[TBL] [Abstract][Full Text] [Related]
24. Novel Stool-Based Protein Biomarkers for Improved Colorectal Cancer Screening: A Case-Control Study.
Bosch LJW; de Wit M; Pham TV; Coupé VMH; Hiemstra AC; Piersma SR; Oudgenoeg G; Scheffer GL; Mongera S; Sive Droste JT; Oort FA; van Turenhout ST; Larbi IB; Louwagie J; van Criekinge W; van der Hulst RWM; Mulder CJJ; Carvalho B; Fijneman RJA; Jimenez CR; Meijer GA
Ann Intern Med; 2017 Dec; 167(12):855-866. PubMed ID: 29159365
[TBL] [Abstract][Full Text] [Related]
25. A fecal-based test for the detection of advanced adenoma and colorectal cancer: a case-control and screening cohort study.
Cao LJ; Peng XL; Xue WQ; Zhang R; Zhang JB; Zhou T; Wu ZY; Li GR; Wang TM; He YQ; Yang DW; Liao Y; Tong XT; Wang F; Chen KX; Zhang SH; Zhu LQ; Ding PR; Jia WH
BMC Med; 2021 Oct; 19(1):250. PubMed ID: 34689777
[TBL] [Abstract][Full Text] [Related]
26. Faecal calprotectin and faecal occult blood tests in the diagnosis of colorectal carcinoma and adenoma.
Tibble J; Sigthorsson G; Foster R; Sherwood R; Fagerhol M; Bjarnason I
Gut; 2001 Sep; 49(3):402-8. PubMed ID: 11511563
[TBL] [Abstract][Full Text] [Related]
27. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
[TBL] [Abstract][Full Text] [Related]
28. Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test.
Otero-Estévez O; De Chiara L; Rodríguez-Berrocal FJ; Páez de la Cadena M; Cubiella J; Castro I; Gonzalez-Mao C; Hernandez V; Martínez-Zorzano VS
Br J Cancer; 2015 Jan; 112(2):375-81. PubMed ID: 25461801
[TBL] [Abstract][Full Text] [Related]
29. Immunochemical fecal occult blood testing is equally sensitive for proximal and distal advanced neoplasia.
de Wijkerslooth TR; Stoop EM; Bossuyt PM; Meijer GA; van Ballegooijen M; van Roon AH; Stegeman I; Kraaijenhagen RA; Fockens P; van Leerdam ME; Dekker E; Kuipers EJ
Am J Gastroenterol; 2012 Oct; 107(10):1570-8. PubMed ID: 22850431
[TBL] [Abstract][Full Text] [Related]
30. The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy.
Wong MC; Ching JY; Chan VC; Sung JJ
Sci Rep; 2015 Sep; 5():13568. PubMed ID: 26338314
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancer.
Ng SC; Ching JY; Chan V; Wong MC; Suen BY; Hirai HW; Lam TY; Lau JY; Ng SS; Wu JC; Chan FK; Sung JJ
Aliment Pharmacol Ther; 2013 Oct; 38(7):835-41. PubMed ID: 23957462
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of one or two faecal haemoglobin and calprotectin measurements in patients with suspected colorectal cancer.
Turvill J; Mellen S; Jeffery L; Bevan S; Keding A; Turnock D
Scand J Gastroenterol; 2018 Dec; 53(12):1526-1534. PubMed ID: 30621475
[TBL] [Abstract][Full Text] [Related]
33. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
[TBL] [Abstract][Full Text] [Related]
34. Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions.
Baxter NT; Ruffin MT; Rogers MA; Schloss PD
Genome Med; 2016 Apr; 8(1):37. PubMed ID: 27056827
[TBL] [Abstract][Full Text] [Related]
35. Proton pump inhibitors reduce the accuracy of faecal immunochemical test for detecting advanced colorectal neoplasia in symptomatic patients.
Rodriguez-Alonso L; Rodriguez-Moranta F; Arajol C; Gilabert P; Serra K; Martin A; Ibáñez-Sanz G; Moreno V; Guardiola J
PLoS One; 2018; 13(8):e0203359. PubMed ID: 30169524
[TBL] [Abstract][Full Text] [Related]
36. Diagnosing colorectal cancer and inflammatory bowel disease in primary care: The usefulness of tests for faecal haemoglobin, faecal calprotectin, anaemia and iron deficiency. A prospective study.
Högberg C; Karling P; Rutegård J; Lilja M
Scand J Gastroenterol; 2017 Jan; 52(1):69-75. PubMed ID: 27623716
[TBL] [Abstract][Full Text] [Related]
37. DIAGNOSTIC ACCURACY OF ONE SAMPLE OR TWO SAMPLES QUANTITATIVE FECAL IMMUNOCHEMICAL TESTS FOR INTESTINAL NEOPLASIA DETECTION.
Mattar R; Marques SB; Minata MK; Silva-Etto JMKD; Sakai P; DE Moura EGH
Arq Gastroenterol; 2020; 57(3):316-322. PubMed ID: 32935747
[TBL] [Abstract][Full Text] [Related]
38. An analysis of the duplicate testing strategy of an Irish immunochemical faecal occult blood test colorectal cancer screening programme.
Kelley L; Swan N; Hughes DJ
Colorectal Dis; 2013 Sep; 15(9):e512-21. PubMed ID: 23746062
[TBL] [Abstract][Full Text] [Related]
39. Testing for faecal calprotectin (PhiCal) in the Norwegian Colorectal Cancer Prevention trial on flexible sigmoidoscopy screening: comparison with an immunochemical test for occult blood (FlexSure OBT).
Hoff G; Grotmol T; Thiis-Evensen E; Bretthauer M; Gondal G; Vatn MH
Gut; 2004 Sep; 53(9):1329-33. PubMed ID: 15306594
[TBL] [Abstract][Full Text] [Related]
40. Faecal immunochemical tests versus guaiac faecal occult blood tests: what clinicians and colorectal cancer screening programme organisers need to know.
Tinmouth J; Lansdorp-Vogelaar I; Allison JE
Gut; 2015 Aug; 64(8):1327-37. PubMed ID: 26041750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]